Refractory chronic erythema nodosum successfully treated with adalimumab.
Ortego-Centeno
N
N
Callejas-Rubio
J L
JL
Sanchez-Cano
D
D
Caballero-Morales
T
T
D000068879:Adalimumab; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002908:Chronic Disease; D004893:Erythema Nodosum / Q000188:drug therapy*; D006801:Humans; D008297:Male
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab